Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, announced that our insulin titration solution, DoseCheck, will now help patients and their care teams manage their insulin and glucose in yet another country. We’re also proud to now be one of the only digital platform companies connecting healthcare providers, payers and life sciences companies on four continents!
About Amalgam Rx
Amalgam reimagines health care by helping patients and providers make the best decisions possible – in the provider workflow and in patients’ everyday lives. Through a suite of EHR Solutions and a modular SaMD platform, Amalgam enables the leading life sciences companies, health plans, and provider organizations to collaboratively deliver better care. Today, Amalgam’s algorithms and applications support nearly 10 million patients across 4 continents and have helped providers make over 50 million decisions. For more information on how Amalgam Rx’s regulated, clinically validated technologies bring patients and providers closer together, reduce costs for payers, and unlock sustained value for our partners, visit amalgamrx.com.